Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Thank you for joining us!Our session will begin shortly…
While you are waiting, please feel free to
©2014 Waters Corporation 1
While you are waiting, please feel free to browse our library of program content: www.waters.com/meettheexperts
Also, click below to learn more about CORTECS, our newest Solid-Core LC Column platform:
www.waters.com/CORTECS
� Please use text chat functionality to submit your
questions today.
� Poll Questions – Audience participation
� Providing ‘Live’ Technical Support during today’s event
� Upon conclusion, follow up information will be available:
Friendly Reminders…
©2014 Waters Corporation 2
� http://www.waters.com/June12
� Recorded version of today’s presentation
� PDF Copy of today’s slides
� Product discount offers
� Product specific information and reference materials
Today’s SpeakerToday’s Speaker
©2014 Waters Corporation 3
Bill Warren has been with Waters Corporation for more than 20 years,
having worked in both technical and marketing capacities. He is
currently responsible for strategic and tactical implementation of
programs that support new bioseparations products and technologies
which help accelerate customer productivity in the biopharmaceutical
market segment.
©2014 Waters Corporation 4
Applications of UPLCApplications of UPLCBioseparationsBioseparations
Time30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00 80.00 85.00 90.00
AU
2.0e-2
3.0e-2
4.0e-2
5.0e-2
6.0e-2
7.0e-2
8.0e-2
9.0e-2
30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00 80.00 85.00 90.00
AU
1.0e-2
1.5e-2
2.0e-2
2.5e-2
3.0e-2
3.5e-2
4.0e-2
4.5e-2
5.0e-2
5.5e-2
6.0e-2
6.5e-2
7.0e-2
7.5e-2
HPLC
UPLC
AM
Q
NH
3 His S
er
Arg
Gly A
sp
Glu T
hr
Ala
Pro
De
riv
Pe
ak
Cy
sL
ys
Ty
rM
et
Va
l
Ile
Le
uP
he
Minutes
1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00
Amino Acid Analysis
40T
2 minutes 11
50T
60T
UV 260 nm
Oligonucleotides1 G02 G0F
6
11
2
©2014 Waters Corporation 5
Peptide MappingOligonucleotides2 G0F
3 Man54 G0FGN5 G16 G1Fa7 G1Fb8 G1FGN9 Man610 G211 G2F12 G1F+SA13 G2F+SA
1
4
5
78
9
10
3
12
13
Glycan Analysis
cytochrome c
MonoclonalAntibody
BSAMyoglobin
Enolase
Phosphorylase b
Protein Reversed Phase
AU
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.22
Minutes
0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00 8.50 9.00 9.50 10.00
Protein Size Exclusion
AU
0.000
0.002
0.004
0.006
0.008
AU
0.000
0.002
0.004
0.006
AU
0.000
0.005
0.010
Minutes
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00
pH 6.4
pH 6.6
pH 6.8
Protein Ion Exchange
Topics
� Customer Requested Attributes for Bioseparation Columns
� What Goes into Obtaining “Improved” LC-Based Bioseparations
� Concerns with UPLC to HPLC Method Transferability
� Synthetic Oligonucleotide Analyses
� Amino Acid Analyses
� Peptide Analyses
©2014 Waters Corporation 6
� Peptide Analyses
� Protein Analyses
� Released Glycan Analyses
Customer Requested Attributes for Customer Requested Attributes for BioseparationBioseparation IEX ColumnsIEX Columns
Type Votes
Weighted
Average Rank
Resolution 91 2.07 1
Column-to-column reproducibility 83 2.52 2
Batch-to-batch reproducibility 79 2.53 3
Volume and mass loading capacity 73 2.64 4
Separation speed 80 2.70 5
©2014 Waters Corporation 7
Source:Waters Web Survey
(4,760 contacted / 196 responses)
QC tested with biomolecules (e.g. proteins) 56 2.75 6
Column lifetime 77 2.92 7
Price 73 2.96 8
Non-metallic hardware 55 3.00 9
Matching guard column 53 3.28 10
Other 21 3.48 11
The weighted averages were calculate by: ((#5's*5)+(#4's*4)=(#3's*3)+(#2's*2)+#1's)/5
RED: Particles and System Synergy
GREEN: Particles and Manufactury Synergy
How to Build Resolution:Efficiency with Selectivity
©2014 Waters Corporation 8
Late 1970’s10µ Irregular micro-porous
1000-2500 psi25,000 plates/meter
3.9 x 300mm
Particle Size EvolutionParticle Size Evolution
Early 1970’s40µ pellicular non-porous coated
100-500 psi1000 plates/meter
1m columns
10 min
©2014 Waters Corporation 9
10 min
1980’s to present day5 – 2.5µ spherical micro-porous
1500-4000 psi50,000 - 80,000 plates/meter
3.9 x 150mm
10 min
10 min
eÉáÖÜí=bèìáî~
äÉåí=íç
=qÜÉ
çêÉíáÅ~ä=mä~íÉ
içïÉëí=ebqm=Z[=léíáãìã=mä~íÉ=`çìåí
ebqm=======mi q̂bp
`=qÉêã
Particle Size and Flow RateParticle Size and Flow Ratevan van DeemterDeemter EquationEquation
A term + B term + C term
H = a(dp) + b + c(dp)2uu
©2014 Waters Corporation 10
^=qÉêãEm~êíáÅäÉ=ëáòÉ=~åÇ=Üçï=ïÉää=ÄÉÇ=
ï~ë=é~ÅâÉÇF
eÉáÖÜí=bèìáî~
äÉåí=íç
=qÜÉ
çêÉíáÅ~ä=mä~íÉ
iáåÉ~ê=sÉäçÅáíó
ebqm
u ôÅãLëÉÅõ
e
`=qÉêãEj~ëë=íê~åëÑÉêF
_=qÉêãEiçåÖáíìÇáå~ä=aáÑÑìëáçåF
^ÇÇ=íÜÉ=P=íÉêãë=íç=çÄí~áå=Ñáå~ä=/î~å=aÉÉãíÉê=`ìêîÉÒ
Chromatography PrinciplesChromatography PrinciplesMass Transfer / DiffusionMass Transfer / Diffusion
Analyte Molecules
Mobile Phase
A
Adsorption Equilibria
©2014 Waters Corporation 11
Porous
ParticleB
CDiffusion-related band broadening
Smaller ParticlesSmaller ParticlesThe enabler of productivityThe enabler of productivity
©2014 Waters Corporation 12
Where Does Band Spreading / Where Does Band Spreading / System Dispersion Occur?System Dispersion Occur?
©2014 Waters Corporation 13
Band Spreading: 1) From the Injector2) Into, through and out
of the column3) Into the Detector
Extra ColumnWithin Column
Band Spreading, Peak Height Band Spreading, Peak Height and Resolutionand Resolution
LC systems (column and instrument) capable of producing narrower/sharper bands create narrower/sharper peaks
This results in better resolution, taller peaks and better sensitivity
System withMORE
System with LESS
©2014 Waters Corporation 14
Better separationMore concentrated “Bands”Higher Sensitivity
Both analytes (blue and red) are not separated [a partial co-
elution – shown as a “purple” band]
MOREBand Spreading
LESSBand Spreading
Narrow PeakIncreased SensitivityIncreased Resolving
Power
UPLC®
TechnologyBroad BandBroad Peak
Less SensitivityLess Resolving Power
HPLC
Impact of Band Spreading on Resolution
©2014 Waters Corporation 15
Requires Columns and Instrumentation to Minimize
Band Spreading
Sources of Band Spreading –Improper Column Connection
Band SpreadingDead / Void Volume
Improper
Resulting Peak Shape
©2014 Waters Corporation 16
Proper
PackedBedOf
Particles
No Dead Volume
HPLC HPLC vsvs UPLC SEC Analysis of UPLC SEC Analysis of Insulin Insulin DimerDimer vsvs MonomerMonomer
©2014 Waters Corporation 17
HPLC HPLC vsvs UPLC ReversedUPLC Reversed--Phase GradientPhase GradientAnalysis of Analysis of DerivitizedDerivitized Amino AcidsAmino Acids
4 µm Particles
©2014 Waters Corporation 18
1.8 µm Particles
UltraPerformance LCUltraPerformance LC®® TechnologyTechnology
� A class of separation science
– Based on chromatography columns with very small particles
– Based on instruments designed and manufactured to take advantage
of the small particles
� Improves resolution, sensitivity, and speed with no
©2014 Waters Corporation 19
� Improves resolution, sensitivity, and speed with no
compromises to results
� Suitable for chromatographic applications in general
– Appropriate for developing new methods
– Appropriate for improving existing methods
– SCALEABLE CHEMISTRIES FROM UPLC TO HPLC IF NEEDED
Importance of Method TransferabilityImportance of Method TransferabilityFrom Drug Discovery, Development and From Drug Discovery, Development and ManufacturingManufacturing
©2014 Waters Corporation 20
Ethylene Bridged Hybrid (BEH) Ethylene Bridged Hybrid (BEH) Particles TechnologyParticles Technology
Bridged Ethanes within a silica matrix
©2014 Waters Corporation 21U.S. Patent No. 6,686,035 B2
Importance of Batch to Batch and Importance of Batch to Batch and Column to Column ReproducibilityColumn to Column Reproducibility
©2014 Waters Corporation 22
Over 30 tests per batch of media totaling over 300 QC response factors
ApplicationApplication--specific Columnsspecific ColumnsACQUITY UPLC BEH Glycan ColumnACQUITY UPLC BEH Glycan Column
Chromatographic Testwith
Biomolecule Standards
Chemical Tests
Individual Column Tests
©2014 Waters Corporation 23
Manufacturing ConsistencyManufacturing ConsistencyACQUITY UPLC Glycan BEH Amide Columns ACQUITY UPLC Glycan BEH Amide Columns
ACQUITY UPLC BEH Glycan, 1.7µm, 2.1 x 150 mm
©2014 Waters Corporation 24
Quality control testing ensures consistent analyses
UPLC and HPLCUPLC and HPLC--based,based,22--AB Labeled Glycan AnalysesAB Labeled Glycan Analyses
XBridge BEH Glycan 2.5 µm XP
ACQUITY BEH Glycan 1.7 µm
EU
0.00
2.00
4.00
6.00
10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00
1 2
4
3
5
6
7
8910
11
12
14
20.00
Alliance HPLC
UPLC
13
Pc*half-height = 110
Pc*half-height = 78
2.1 x 150 mm0.50 mL/min
2.1 x 150 mm
UPLC-based
HPLC-based
8700 psi (Column, Max)
3300 psi (Column, Max)
©2014 Waters Corporation 25
EU
0.00
10.00
20.00
15.00 20.00 25.00 30.00 35.00 40.00
XBridge BEH Glycan 3.5 µm
EU
0.00
5.00
10.00
Minutes25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00
Alliance HPLCPc
*half-height = 55
2.1 x 150 mm0.34 mL/min
2.1 x 150 mm0.24 mL/min
HPLC-based
3300 psi (Column, Max)
990 psi (Column, Max)
50.0
20
25
% Abundance
1.7 um, 0.50 mL/min)
2.5 um XP, 0.34 mL/min
3.5 um, 0.24 mL/min
UPLC UPLC vsvs HPLC Relative Abundance HPLC Relative Abundance DeterminationsDeterminations
1
2
3
4
5
6,7
8
9
10
11
12
13
14
15,16
©2014 Waters Corporation 26
n=30
5
10
15
Peak 1 G0-GN
Peak 2 G0
Peak 3 G0F
Peak 4 Man5
Peak 5 G0FN
Peak 6 G1F
Peak 7 G1F
Peak 8 G1FN
Peak 9 Man6
Peak 10 G2
Peak 11 G2F
Peak 12 G2FN
Peak 13 G1FS1
Peak 14 G2FS1
Peak 15 A3
Peak 16 A3
% Abundance
*Peaks 8 and 9 – 3.5 µm resolution insufficient, accuracy of the integration is poor
Influence of ExtraInfluence of Extra--Column Band Column Band Spreading on Gradient SeparationsSpreading on Gradient Separationswith 1.6um Particleswith 1.6um Particles
12000
14000
16000
18000
20000
Efficiency (Plate Count)
Waters ACQUITY UPLC I-ClassN = 18,315
Waters ACQUITY UPLC H-ClassN = 14,072
Dionex Ultimate
Agilent 1290N = 9,392
CORTECS UPLC C18+2.1 x 50 mm, 1.6 µm
©2014 Waters Corporation 27
0
2000
4000
6000
8000
10000
0 5 10 15 20 25 30 35 40 45 50
Efficiency (Plate Count)
Band spreading (µL, 5 sigma)
Journal of Chromatography A, 1216 (2009) 5979–5988
Dionex Ultimate 3000
N = 10,974
N = 9,392
Shimadzu NexeraN = 6,913
Agilent 1200N = 6,266
Waters Alliance 2695
N = 2,704
Gradient offset aligns chromatograms Gradient offset aligns chromatograms Different instruments and dwell volumeDifferent instruments and dwell volume
* *
No Gradient Offset Programmed Gradient Offset
HPLC HPLC
©2014 Waters Corporation 28
Retention Time (min)
10 15 20 25 30 35 40 45
Retention Time (min)
10 15 20 25 30 35 40 45
H-Class Bio
Sample: Waters MassPrep PepmixInjection Vol: 95 µlSolvent A: H2O with 0.1% TFASolvent B: MeCN with 0.1% TFA
H-Class Bio
Peptide Mapping of complex separationsPeptide Mapping of complex separationsTrypsinizedTrypsinized RibonucleaseRibonuclease B B
AU
0.2
0.4
0.6
1
4
7
10
11 12
14
15
13
16
17
18 21
2223 24
25
26
2728
29
30
31
32
A
*
Sample: Ribonuclease BPeptidase: Trypsin V5111Injection Vol: 95µlSolvent A: H2O with 0.1% TFASolvent B: MeCN with 0.1% TFA
Relative Retention Time Comparison
HPLC
©2014 Waters Corporation 29
Minutes
10 15 20 25 30 35 40
0.0
AU
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1
2 356
7
89 19 20 33
1
2 3
4
56
7
89
1011 12
14
15
13
16
17
18
19 20
21
2223 24
25
26
27
2829
30
31
32
33
B
*
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
2.6
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33
Rela
tiv
e R
ete
nti
on
Tim
e
Peak Number
HPLCH-Class Bio
Relative Retention Time Comparison
H-Class Bio
Peptide Mapping of complex separations Peptide Mapping of complex separations TrypsinizedTrypsinized InfliximabInfliximab
8 15
23
26
29
33
3436
37
38
48
49
51
AU
0.00
0.05
0.10
0.15
AU
0.06
0.08
0.10
0.12
12
34
5 6
7
8
9
10
13
14
15
1617
1819 20
21
22
23
24
25
26
27
28
29
30
3132
33
34
35
36
373839
40
41
42
4344
4546
47
48
4950
51
5253
54 55
56
1112
Sample: InfliximabPeptidase: Trypsin
V5111Inj. Vol: 95µlSolvent A: H2O Solvent B: MeCNSolvent C: 1% TFASolvent D: H2O
H-Class Bio
H-Class Bio
HPLC
©2014 Waters Corporation 30
�A total of 56 peptide peaks were selected for
monitoring
�Approximately 90 peaks were identified within the
chromatographic space.
12
3
4
56
7
8
9
10
1112
13
14
15
16
17
1819 20
21
22
24
25
27
28
30
31
32
34
35
3638
3940
41
42
4344
4546
47
49
5052
53
54 55
56
AU
0.02
0.04
0.06
Retention Time (min)
12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
UPLCUPLC®® Technology Technology
©2014 Waters Corporation 31
UPLCUPLC Technology Technology
for Synthetic for Synthetic
Oligonucleotide Oligonucleotide
SeparationsSeparations
� Principles of Ion-Pair, Reversed-Phase Chromatography for
Synthetic Oligonucleotides
– Ion-pairing systems
– Performance, optimization, MS compatibility
� Oligonucleotide Separation Technology (OST)
©2014 Waters Corporation 32
� Oligonucleotide Separation Technology (OST)
– Importance of sorbent particle size
Retention Mechanism of “Retention Mechanism of “TritylTrityl--Off” Off” ChromatographyChromatography
RP with ion-pairing agent
- charge-charge interaction (oligo backbone)
- hydrophobicity (nucleobases)
Reversed-phase interaction
- hydrophobicity of the nucleobases
1520
2535
3015
2025
30
©2014 Waters Corporation 33
+
+++ --
-
-
--
--
+C18 sorbent
0 minutes 100 minutes 10
35
TEA+
TEA+ layer on the column surface
Several Different IonSeveral Different Ion--Pairing Reagents Pairing Reagents Available for Synthetic Oligo RP SeparationsAvailable for Synthetic Oligo RP Separations
Ion pairing agent buffering acid Abbreviation
Triethylammonium acetate TEAA
Triethylammonium bicarbonate TEAB
Dimetylbutylammonium acetate DMBAA
©2014 Waters Corporation 34
Tributylammonium acetate TBAA
Tripropylammonium acetate TPAA
Hexylammonium acetate HAA
Triethylammonium hexafluoroisopropanol TEA-HFIP
Triethylammonium Acetate Reagent
UV 260 nm 24
11 12 13 14 1516+17
18+19
20
21 22
23
25
28
29
30
Comparison of TEAA vs. TEAComparison of TEAA vs. TEA--HFIP forHFIP forthe IPthe IP--RP Separation of the same RP Separation of the same 30mer Oligo Synthesis Mixture30mer Oligo Synthesis Mixture
©2014 Waters Corporation 35
Triethylammonium HFIP Reagent
0 30Minutes
13 14 15 16
18
20
2122
26
29
25
28
30
27
24
23
19
171211
10 32Minutes
UV 260 nm
T
G
GG
C
G
A
TTT
C
C
TGTTAAGT
AgendaAgenda
� Principles of Ion-Pair, Reversed-Phase Chromatography for
Synthetic Oligonucleotides
– Ion-pairing systems
– Performance, optimization, MS compatibility
©2014 Waters Corporation 36
� Oligonucleotide Separation Technology (OST)
– Importance of sorbent particle size
Importance of Sorbent Particle Size:Importance of Sorbent Particle Size:Smaller C18 particles Yield Improved IPSmaller C18 particles Yield Improved IP--RP RP Synthetic Oligo SeparationsSynthetic Oligo Separations
TEA-HFIP, pH 7.9at 0.2 mL/minat 60°C 5 µm
3.5 µm
©2014 Waters Corporation 37
BEH, C18 Particles: 2.1 x 50mm column, 15-60T ladder
8 minutes 28
3.5 µm
2.5 µm
UV 260 nm
Ultimate Separation Performance Obtained Ultimate Separation Performance Obtained using 1.7um Particles with using 1.7um Particles with Waters UPLC® TechnologyWaters UPLC® Technology
40T50T
60T
UV 260 nm
1.7 µmTEA-HFIP, pH 7.9at 0.2 mL/minat 60°C
©2014 Waters Corporation 38
BEH, C18 Particles: 2.1 x 50mm column, 15-60T ladder
2 minutes 11
UV 260 nm
Example of an IPExample of an IP--RP, MS Analysis of a RP, MS Analysis of a
21 mer Synthetic RNA Mixture21 mer Synthetic RNA Mixture
5`5`--UUC UGU AAU CUC UUG UCU ATT UUC UGU AAU CUC UUG UCU ATT --3`3`
©2014 Waters Corporation 39
UPLCUPLC®® TechnologyTechnology
©2014 Waters Corporation 40
UPLCUPLC TechnologyTechnology
for Amino Acid for Amino Acid
AnalysisAnalysis
Challenges for Amino Acid Analysis
� Difficult analytical problem
– Separation
o Wide range of properties
o Slight differences between pairs
o Wide range of matrices
– Detection
©2014 Waters Corporation 41
– Detection
o No chromophore
o Wide concentration range
� Analytical method requirements
– Unequivocal identification, accuracy
– Precision and linearity
– Sensitivity and speed
– Rugged and robust method
Chemistry of AQC DerivatizationChemistry of AQC Derivatization
©2014 Waters Corporation 42
� Reacts readily with both primary and secondary amines
� Forms stable derivatives
� Requires no vacuum drying, sample prep or extraction
� Amendable to automation
HPLC and UPLCHPLC and UPLC®® Amino Acid Amino Acid Analysis Methods Analysis Methods
AM
Q
Asp
Ser
Glu
Gly
His
NH
3
Arg
Thr
Ala
Pro
Cys
Tyr
Val
Met
Lys
ILe
Leu
Phe
HPLC
50 MinuteCycle Time
©2014 Waters Corporation 43
AM
Q
NH
3
His
Ser Arg
Gly
Asp G
lu
Thr
Ala P
ro
Cys
Lys
Tyr
Met
Val
NV
a
ILe
Leu
Phe
Minutes
1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00
Minutes
8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00 38.00
UPLC
10 MinuteCycle Time
UPLC® Application Solution for Amino Acid Analysis
� Turn-key UPLC® Amino Acid Analysis application
– Optimized for the ACQUITY UPLC System
– Dedicated QC-tested column and reagents
– Application-specific Performance
©2014 Waters Corporation 44
– Application-specific Performance Qualification
– Same result day-to-day, instrument-to-instrument, lab-to-lab, around the world
� Target Applications
– Protein and peptide ID and quantitation
– Monitoring cell culture media
Solution: UPLC™ AAA SolutionSolution: UPLC™ AAA Solution
AM
Q
GA
BA H
yL
ys1
HyL
ys2
Orn
Deri
v P
eak
Cys
Lys
Tyr
Met
Val NV
a
Ile
Leu
Ph
eT
rp
AU
0.040
0.045
0.050
0.055
0.060
0.065
0.070
0.075
0.080
0.085
0.090
0.095
0.100
©2014 Waters Corporation 45
NH
3H
yP
roH
is Asn Tau
Ser
Gln
Arg G
ly Asp G
lu Th
r
Ala
GA
BA
Pro
HyL
ys1
HyL
ys2
AA
BA
-0.005
0.000
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
Minutes1.00 1.50 2.00 2.50 3.00 3.50 4.00 4.50 5.00 5.50 6.00 6.50 7.00 7.50 8.00
• 7X improvement in throughput
•Eliminated need for outsourcing
•Same day turnaround of samples
“I was totally amazed that we were able to separate this set of amino acids in nine minutes when, not long ago, it took several hours.” VP, Process Development
Amino Acid Analyses of Amino Acid Analyses of Cell Cell Culture SampleCulture Sample
6 day
©2014 Waters Corporation 46
Ser
Gln
Arg
Gly Asp
Glu
Thr
Ala
Minutes
2.40 2.60 2.80 3.00 3.20 3.40 3.60 3.80 4.00 4.20 4.40 4.60 4.80 5.00
1 day
3 day
UPLCUPLC®® TechnologyTechnology
©2014 Waters Corporation 47
UPLCUPLC TechnologyTechnology
for Peptide for Peptide
MappingMapping
“Ideal” Protein Digestion
IntactProtein Complete Digestion
without generation of modified peptides
©2014 Waters Corporation 48
The Reality of Many Protein Digestions
IntactProtein
Complete Digestion withoutgeneration of modified peptides
©2014 Waters Corporation 49
Non-specificCleavages
IncompleteDigestion
Non-Cleavage
MiscleavagesHydrophobic
Protein that may havesolubility issues
0.0015
0.002
0.0025
250 µµµµL/min2.1 mm Column
25 µµµµL/min2.1 mm Column
Plate Height (H
)
3.5 µµµµm
Increase in chromatographic
van Deemter Plot1500da Peptide
©2014 Waters Corporation 50
0
0.0005
0.001
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2
Linear Velocity (mm/sec)
Plate Height (H
)
1.7 µµµµm
chromatographicresolution
AU
2.0e-2
2.5e-2
3.0e-2
3.5e-2
4.0e-2
4.5e-2
5.0e-2
5.5e-2
6.0e-2
6.5e-2
7.0e-2
7.5e-2 HPLCPeak Capacity
= 372
HPLC 2.1 x 250 mm, 3.5 µm
Improve ResolutionSame Run Time
©2014 Waters Corporation 51
Time30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00 80.00 85.00 90.00
AU
2.0e-2
3.0e-2
4.0e-2
5.0e-2
6.0e-2
7.0e-2
8.0e-2
9.0e-2
30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00 80.00 85.00 90.00
1.0e-2
1.5e-2
2.0e-2
UPLCPeak Capacity
= 723
UPLC 2.1 x 150 mm, 1.7 µm
AU
2.0e-2
3.0e-2
4.0e-2
5.0e-2
6.0e-2
7.0e-2
90 min
HPLC 2.1 x 250 mm, 3.5 µm
Reduce Run TimeComparable Resolution
©2014 Waters Corporation 52
Time20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00 38.00 40.00 42.00 44.00 46.00 48.00 50.00 52.00 54.00 56.00
AU
2.0e-2
3.0e-2
4.0e-2
5.0e-2
6.0e-2
7.0e-2
8.0e-2
9.0e-2
1.0e-1
Time30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00 80.00 85.00 90.00
1.0e-2
2.0e-2
55 min
UPLC 2.1 x 150 mm, 1.7 µm
Peptide MapPeptide MapTrace ContaminantTrace Contaminant
2.0e-1
22.39
15.54
34.17
29.65
28.60
23.86
©2014 Waters Corporation 53
Time10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00
AU
5.0e-2
1.0e-1
1.5e-1
9.75
18.00
23.86
24.7127.94
32.84
*
9.5e-2
1.0e-1
1.05e-1
1.1e-1
1.15e-1
1.2e-1
1.25e-1
1.3e-1
1.35e-1
1.4e-1
Peptide MapPeptide MapTrace ContaminantTrace Contaminant
©2014 Waters Corporation 54
Time28.30 28.35 28.40 28.45 28.50 28.55 28.60 28.65 28.70 28.75 28.80 28.85 28.90 28.95 29.00 29.05
AU
2.0e-2
2.5e-2
3.0e-2
3.5e-2
4.0e-2
4.5e-2
5.0e-2
5.5e-2
6.0e-2
6.5e-2
7.0e-2
7.5e-2
8.0e-2
8.5e-2
9.0e-2
0.2%
0.5%
1%
2%**
UPLCUPLC®® Technology Technology
©2014 Waters Corporation 55
UPLCUPLC Technology Technology
for Protein for Protein
SeparationsSeparations
Challenges for Protein SeparationsChallenges for Protein Separations
� Requires the detection of small chemical differences between
quite large molecules
� Employs a variety of analytical techniques that are sensitive to
a different property of the proteins
– Size exclusion for changes in size or aggregation
– Reversed-phase for detecting a wide range of small changes
©2014 Waters Corporation 56
– Reversed-phase for detecting a wide range of small changes
– Ion-exchange for changes in net charge
Carbohydrate Groups
Hydrophobic Regions
Disulfide Linkages
Aromatic Groups
HydrogenBonding
Net Charge
HPLC HPLC vsvs UPLC SEC Analysis of UPLC SEC Analysis of Insulin Insulin DimerDimer vsvs MonomerMonomer
©2014 Waters Corporation 57
UPLCUPLC®® TechnologyTechnology
for Glycans Analysisfor Glycans Analysis
©2014 Waters Corporation 58
for Glycans Analysisfor Glycans Analysis
UPLC UPLC vsvs HPLC Analysis ofHPLC Analysis of22--AB Labeled NAB Labeled N--Linked GlycansLinked Glycans
6
3
6
3
Glycan Release
Glycoprotein
6
3
6
3
Oligosaccharides
©2014 Waters Corporation 59
6
3
6
3
Protease Digestion
Glycopeptides
Glycoprotein Oligosaccharides(Glycans)
Monosaccharides
Separation of 2Separation of 2--AB Labeled IgG on AB Labeled IgG on ACQUITY UPLC Glycan BEH AmideACQUITY UPLC Glycan BEH Amide(HILIC) Column(HILIC) Column
©2014 Waters Corporation 60
SummarySummary
� Holistic approach to separation science
– UPLC® improves resolution, sensitivity, and speed
– Application specific chemistries
– Low dispersion system
– Better separation benefits downstream detection methods
o UV or PDA
o FLR
o Mass Spectrometry
©2014 Waters Corporation 61
� UPLC is an innovative technology that can be routinely applied to all aspects of biotherapeutic proteins analysis
– Synthetic Oligonucleotides
– Amino Acid Analysis
– Peptide Separations
– Intact Proteins
– Glycan Analysis
� Waters recognizes need for both UPLC and HPLC Bioseparations Solutions and hasofferings and tools to assist in Worldwide Implementation of selected method(s).
Thank You for Attending!Thank You for Attending!
� Post-Event Landing Page…
� www.waters.com/June12
– 30% Promotional Offer On BioSeparations Columns
– Full Webinar Recording of Today’s Session w/PDF Slide
Deck
– Compilation of TODAY’S KEY Literature, Brochures etc…
©2014 Waters Corporation 62
– Compilation of TODAY’S KEY Literature, Brochures etc…
� For Questions and to Submit your Ideas for our Next Topic
– Please eMail - [email protected]